Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices

European Journal of Cardio-thoracic Surgery

Volumn 31, Issue 4, 2007, Pages 698-702

  Zimpfer, Daniel ^a   Zrunek, Philipp ^a   Sandner, Sigrid ^a   Schima, Heinz ^a   Grimm, Michael ^a   Zuckermann, Andreas ^a   Wolner, Ernst ^a   Wieselthaler, Georg ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Heart assist devices; Heart disease; Heart failure; Pulmonary hypertension; Transplantation

Indexed keywords

GLYCERYL TRINITRATE; LEVOSIMENDAN; NITRIC OXIDE; PROSTACYCLIN;

ACUTE HEART FAILURE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART ASSIST DEVICE; HEART DISEASE; HEART GRAFT; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HUMAN; IMPLANT; LOG RANK TEST; LUNG VASCULAR RESISTANCE; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL; SURVIVAL TIME; TIME SERIES ANALYSIS;

CARDIAC OUTPUT, LOW; CARDIOMYOPATHIES; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947146234     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.12.036     Document Type: Article

References (15)

1. Costard-Jackle A., and Fowler M.B. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 19 1 (1992) 48-54
2. Erickson K.W., Costanzo-Nordin M.R., O'Sullivan E.J., Johnson M.R., Zucker M.J., Pifarre R., Lawless C.E., Robinson J.A., and Scanlon P.J. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant 9 (1990) 526-537
3. Elefteriades J.A., Lovoulos C.J., Tellides G., Goldstein L.J., Rocco E.J., Condos S.G., and Kopf G.S. Right ventricle-sparing heart transplant: promising new technique for recipients with pulmonary hypertension. Ann Thorac Surg 69 6 (2000) 1858-1863
4. Haddad H., Elabbassi W., Moustafa S., Davies R., Mesana T., Hendry P., Masters R., and Mussivand T. Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension. ASAIO J 51 4 (2005) 456-460
5. Martin J., Siegenthaler M.P., Friesewinkel O., Fader T., van de Loo A., Trummer G., Berchtold-Herz M., and Beyersdorf F. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 25 6 (2004) 971-977
6. Salzberg S.P., Lachat M.L., von Harbou K., Zund G., and Turina M.I. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg 27 2 (2005) 222-225
7. Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L, Grimm M, Rajek A, Wolner E, Wieselthaler G. Left ventricular assist devices lower fixed pulmonary hypertension in cardiac Tx candidates. J Thorac Cardiovasc Surg, in press.
8. Akasaka T., Lythall D., Cheng A., Yoshida K., Yoshikawa J., Mitchell A., and Yacoub M.H. Continuous aortic regurgitation in severely dysfunctional native hearts after heterotopic cardiac transplantation. Am J Cardiol 63 20 (1989) 1483-1488
9. Bleasdale R.A., Banner N.R., Anyanwu A.C., Mitchell A.G., Khaghani A., and Yacoub M.H. Determinants of outcome after heterotopic heart transplantation. J Heart Lung Transplant. 21 8 (2002) 867-873
10. Wieselthaler G.M., Schima H., Hiesmayr M., Pacher R., Laufer G., Noon G.P., DeBakey M., and Wolner E. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation 101 4 (2000) 356-359
11. Pennington D.G., McBride L.R., and Swartz M.T. Implantation technique for the Novacor left ventricular assist system. J Thorac Cardiovasc Surg 108 4 (1994) 604-608
12. Takatani S., Matsuda H., Hanatani A., Nojiri C., Yamazaki K., Motomura T., Ohuchi K., Sakamoto T., and Yamane T. Mechanical circulatory support devices (MCSD) in Japan: current status and future directions. J Artif Organs 8 1 (2005) 13-27
13. Anonymous. ACC/AHA guidelines for cardiac catheterizationand cardiac catheterization laboratories. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization. J Am Coll Cardiol 18 (1991) 1149-1182
14. Murali S., Uretsky B.F., Armitage J.M., Tokarczyk T.R., Betschart A.R., Kormos R.L., Stein K.L., Reddy P.S., Hardesty R.L., and Griffith B.P. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant 11 (1992) 716-723
15. Siegenthaler M.P., Martin J., van de Loo A., Doenst T., Bothe W., and Beyersdorf F. Implantation of the permanent Jarvik-2000 left ventricular assist device: a single-center experience. J Am Coll Cardiol 39 11 (2002) 1764-1772